Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
JANSSEN NZ LIMITED,Guselkumab,"First-line biologic, psoriatic arthritis where DMARDs are not effective",Guselkumab (TREMFYA),Community and Hospital,
